Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanding the Pool in Orthotopic Heart Transplantation: The Use of Hepatitis C Positive Donor Hearts in Hepatitis C Negative Recipients

NCT03222531 is registered in ClinicalTrials.gov with Mary E. Keebler, MD as lead sponsor.

NCT NCT03222531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03222531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanding the Pool in Orthotopic Heart Transplantation: The Use of Hepatitis C Positive Donor Hearts in Hepatitis C Negative Recipients
Lead sponsor
Mary E. Keebler, MD
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2017
Completion date
June 2, 2026
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac transplant, heart transplant, hepatitis c